Health Equity in Transplant and Advanced Liver Disease
Nov
2026
Description
This session presents current research on health equity and disparities in liver transplantation and advanced liver disease in the United States. There is a significant focus on variable access to lifesaving treatments for end stage liver disease, with variability based on geographic, insurance-based, and racial or ethnic factors.
Presentations
2:00 PM
- 2:15 PM
Convention Center - Bluebird Ballroom 3DEF
Having insurance is not enough: Medicaid insured patients still lack equitable access to listing for liver transplant
Russell Rosenblatt, MD | Abstract Presenter
2:15 PM
- 2:30 PM
Convention Center - Bluebird Ballroom 3DEF
Geographic Disparities Leave Patients in the Western US with Unequal Access to Liver Transplant for Alcohol-Associated Liver Disease
Sharmitha Yerneni, MD | Abstract Presenter
2:30 PM
- 2:45 PM
Convention Center - Bluebird Ballroom 3DEF
Hepatorenal Syndrome Mortality in the United States, 2018–2024: Pre-COVID, COVID-Era, and Post-COVID National Trends and Disparities
Jagadish Koyi | Abstract Presenter
2:45 PM
- 3:00 PM
Convention Center - Bluebird Ballroom 3DEF
Burden of Health-Related Social Needs are Independently Associated with Frailty and Minimal Hepatic Encephalopathy in Compensated Cirrhosis: A Liver Cirrhosis Network Study
Ani Kardashian, MD, MS | Abstract Presenter
3:00 PM
- 3:15 PM
Convention Center - Bluebird Ballroom 3DEF
Hispanic/Latino Liver Transplant Candidates Have Lower Access to Living Donor Liver Transplantation in the United States: A National Competing-Risk Analysis
Tulio L Correa, MD | Abstract Presenter
3:15 PM
- 3:30 PM
Convention Center - Bluebird Ballroom 3DEF
Sex Disparities in the Liver Transplant Journey: From Candidacy to Long-Term Outcomes in a 20-Year US Cohort
Linda Henry, PhD | Abstract Presenter
